How to buy NanoViricides stock | $3.47

NanoViricides, Inc is a biotechnology business based in the US. NanoViricides shares (NNVC) are listed on the NYSE MKT and all prices are listed in US Dollars. NanoViricides employs 17 staff and has a market cap (total outstanding shares value) of USD$38.1 million.

How to buy shares in NanoViricides

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for NanoViricides. Find the stock by name or ticker symbol: NNVC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until NanoViricides reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$3.47, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of NanoViricides, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of NanoViricides. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

NanoViricides share price

Use our graph to track the performance of NNVC stocks over time.

NanoViricides shares at a glance

• Key figures

Information last updated 2020-12-11.

Latest market close	USD$3.47
52-week range	USD$1.87 - USD$19.2
50-day moving average	USD$3.6214
200-day moving average	USD$5.1579
Wall St. target price	USD$14.5
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-2.4

Buy NanoViricides shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy NanoViricides stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of NanoViricides, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NanoViricides price performance over time

Historical closes compared with the close of $3.47 from 2020-12-11

1 week (2021-01-12)	N/A
1 month (2020-12-23)	-0.29%
3 months (2020-10-19)	N/A
6 months (2020-07-19)	N/A

1 year (2020-01-19)	N/A
2 years (2019-01-19)	N/A
3 years (2018-01-19)	N/A
5 years (2016-01-19)	N/A

NanoViricides financials

Gross profit TTM	USD$0
Return on assets TTM	-13.51%
Return on equity TTM	-72.6%
Profit margin	0%
Book value	$2.811
Market capitalisation	USD$38.1 million

TTM: trailing 12 months

Shorting NanoViricides shares

There are currently 760,304 NanoViricides shares held short by investors – that's known as NanoViricides's "short interest". This figure is 3.1% up from 737,202 last month.

There are a few different ways that this level of interest in shorting NanoViricides shares can be evaluated.

NanoViricides's "short interest ratio" (SIR)

NanoViricides's "short interest ratio" (SIR) is the quantity of NanoViricides shares currently shorted divided by the average quantity of NanoViricides shares traded daily (recently around 174782.52873563). NanoViricides's SIR currently stands at 4.35. In other words for every 100,000 NanoViricides shares traded daily on the market, roughly 4350 shares are currently held short.

However NanoViricides's short interest can also be evaluated against the total number of NanoViricides shares, or, against the total number of tradable NanoViricides shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case NanoViricides's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 NanoViricides shares in existence, roughly 70 shares are currently held short) or 0.0755% of the tradable shares (for every 100,000 tradable NanoViricides shares, roughly 76 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against NanoViricides.

Find out more about how you can short NanoViricides stock.

NanoViricides share dividends

We're not expecting NanoViricides to pay a dividend over the next 12 months.

Have NanoViricides's shares ever split?

NanoViricides's shares were split on a 1:20 basis on 24 September 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NanoViricides shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NanoViricides shares which in turn could have impacted NanoViricides's share price.

NanoViricides share price volatility

Over the last 12 months, NanoViricides's shares have ranged in value from as little as $1.87 up to $19.2. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NanoViricides's is 0.7753. This would suggest that NanoViricides's shares are less volatile than average (for this exchange).

NanoViricides overview

NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Frequently asked questions

• What percentage of NanoViricides is owned by insiders or institutions?

  Currently 10.491% of NanoViricides shares are held by insiders and 30.868% by institutions.

• How many people work for NanoViricides?

  Latest data suggests 17 work at NanoViricides.

• When does the fiscal year end for NanoViricides?

  NanoViricides's fiscal year ends in June.

• Where is NanoViricides based?

  NanoViricides's address is: 1 Controls Drive, Shelton, CT, United States, 06484

• What is NanoViricides's ISIN number?

  NanoViricides's international securities identification number is: US6300873022

• What is NanoViricides's CUSIP number?

  NanoViricides's Committee on Uniform Securities Identification Procedures number is: 630087104